The Leeds Teaching Hospitals NHS Trust, Saint James's University Hospital
Welcome,         Profile    Billing    Logout  
 5 Trials 
7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Chalmers, James D
BATMAN, NCT05582798: Bronchiectasis Alpha-1 Augmentation Trial- Modulating Airway Neutrophil Function

Completed
4
20
Europe
Alpha 1-Proteinase Inhibitor 180mg/kg, Prolastin-C Liquid, Alpha 1-Proteinase Inhibitor 120mg/kg, Sodium chloride
University of Dundee
Bronchiectasis Adult
08/24
08/24
MAHALE, NCT05006573 / 2020-004068-24: Efficacy and Safety of Benralizumab in Patients With Non-cystic Fibrosis Bronchiectasis

Hourglass Nov 2024 - Dec 2024 : Regulatory decision in Japan for eosinophilic granulomatosis with polyangiitis
Completed
3
100
Europe, Canada, US, RoW
Benralizumab, Placebo to Benralizumab
AstraZeneca
Non-cystic Fibrosis Bronchiectasis
04/24
04/24
MATINEE, NCT04133909 / 2018-001540-56: Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level

Jan 2024 - Dec 2024: Acceptance of regulatory submission in US (based on MATINEE trial) for COPD
Jan 2024 - Dec 2024: Acceptance of regulatory submission in EU (based on MATINEE trial) for COPD
Jan 2024 - Dec 2024: Data from MATINEE trial for COPD
Jan 2024 - Dec 2024: Acceptance of regulatory submission in China (based on MATINEE trial) for COPD
Hourglass Jul 2024 - Dec 2024 : Regulatory decision in Japan for COPD
Completed
3
806
Europe, Canada, US, RoW
Placebo, Mepolizumab
GlaxoSmithKline, PPD DEVELOPMENT, LP
Pulmonary Disease, Chronic Obstructive
08/24
08/24
CLEAR, NCT04140214 / 2017-000664-14: Randomised Open Label Trial of Hypertonic Saline and Carbocisteine in Bronchiectasis

Recruiting
3
288
Europe
Hypertonic saline, MucoClear 6%, HTS, Carbocysteine 750 MG, Mucodyne
Belfast Health and Social Care Trust, Queen's University, Belfast
Bronchiectasis
09/24
09/24
VitalBE, NCT03696290 / 2018-001590-24: Value of Inhaled Treatment With Aztreonam Lysine in Bronchiectasis

Recruiting
2
77
Europe
Aztreonam lysine, Cayston, Placebo, Lactose monohydrate
University of Dundee, Gilead Sciences
Bronchiectasis Adult
09/25
09/25
NCT06166056: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled CHF6333 After Single Doses in Healthy Volunteers and After Single and Repeated Doses in Subjects With Bronchiectasis

Recruiting
1/2
45
Europe
CHF6333, CHF6333 Placebo
Chiesi Farmaceutici S.p.A.
Bronchiectasis
06/25
06/25
BRIDGE, NCT03791086: The Study - Bronchiectasis Research Involving Databases, Genomics and Endotyping

Recruiting
N/A
1000
Europe
University of Dundee
Bronchiectasis Adult
02/27
02/27

Download Options